Literature DB >> 9757047

Receptors and effects of the inhibitory neuropeptide somatostatin in microglial cells.

J Feindt1, A Schmidt, R Mentlein.   

Abstract

The expression of receptors for the neuropeptide somatostatin was investigated in cultured immunocytochemically pure rat microglial cells. By the reverse transcriptase-polymerase chain reaction, the mRNAs for the receptor subtypes sst2, sst3 and sst4, but not sst1 and sst5 could be detected. To show that these receptors were functionally active, the effects of somatostatin and the metabolically stable, receptor subtype (2, 3 and 5) selective derivative octreotide (SMS 201-995, Sandostatin) on protein phosphorylation and proliferation were evaluated. Somatostatin induced the tyrosine phosphorylation of a 95 kDa protein in microglia. Furthermore, somatostatin or octreotide inhibited the basal as well as the GM-CSF-(granulocyte macrophage colony-stimulating factor) or the IL-3-(interleukin-3)-stimulated proliferation of microglial cells. This effect was dose-dependent, with a half maximum activity of about 0.2-0.3 nM. Somatostatin was relatively stable in the cultures due to protease inhibitors in the serum. The results indicate that microglial cells are targets for the widespread neuropeptide somatostatin and that its receptors can transduce complex signals to microglia. Copyright 1998 Elsevier Science B.V.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9757047     DOI: 10.1016/s0169-328x(98)00184-3

Source DB:  PubMed          Journal:  Brain Res Mol Brain Res        ISSN: 0169-328X


  9 in total

1.  Novel Somatostatin Receptor-4 Agonist SM-I-26 Mitigates Lipopolysaccharide-Induced Inflammatory Gene Expression in Microglia.

Authors:  Ashok Silwal; Austin House; Karin Sandoval; Shaluah Vijeth; David Umbaugh; Albert Crider; Shirin Mobayen; William Neumann; Ken A Witt
Journal:  Neurochem Res       Date:  2021-11-30       Impact factor: 3.996

Review 2.  Colony stimulating factors in the nervous system.

Authors:  Violeta Chitu; Fabrizio Biundo; E Richard Stanley
Journal:  Semin Immunol       Date:  2021-11-04       Impact factor: 11.130

3.  Distinct modulation of microglial amyloid β phagocytosis and migration by neuropeptides (i).

Authors:  Sigal Fleisher-Berkovich; Talia Filipovich-Rimon; Sarit Ben-Shmuel; Claudia Hülsmann; Markus P Kummer; Michael T Heneka
Journal:  J Neuroinflammation       Date:  2010-10-11       Impact factor: 8.322

4.  Interaction of transforming growth factor-beta (TGF-beta) and epidermal growth factor (EGF) in human glioma cells.

Authors:  Janka Held-Feindt; Björn Lütjohann; Hendrik Ungefroren; Hubertus M Mehdorn; Rolf Mentlein
Journal:  J Neurooncol       Date:  2003-06       Impact factor: 4.130

5.  Somatostatin modulates insulin-degrading-enzyme metabolism: implications for the regulation of microglia activity in AD.

Authors:  Grazia Tundo; Chiara Ciaccio; Diego Sbardella; Mariaserena Boraso; Barbara Viviani; Massimiliano Coletta; Stefano Marini
Journal:  PLoS One       Date:  2012-04-03       Impact factor: 3.240

Review 6.  Neuropeptides and Microglial Activation in Inflammation, Pain, and Neurodegenerative Diseases.

Authors:  Lila Carniglia; Delia Ramírez; Daniela Durand; Julieta Saba; Juan Turati; Carla Caruso; Teresa N Scimonelli; Mercedes Lasaga
Journal:  Mediators Inflamm       Date:  2017-01-05       Impact factor: 4.711

7.  NNC 26-9100 increases Aβ1-42 phagocytosis, inhibits nitric oxide production and decreases calcium in BV2 microglia cells.

Authors:  Joseph Schober; Jahnavi Polina; Field Walters; Nathan Scott; Eric Lodholz; Albert Crider; Karin Sandoval; Ken Witt
Journal:  PLoS One       Date:  2021-07-08       Impact factor: 3.240

8.  Anti-inflammatory and immune therapy for Alzheimer's disease: current status and future directions.

Authors:  Douglas Walker; Lih-Fen Lue
Journal:  Curr Neuropharmacol       Date:  2007-12       Impact factor: 7.363

9.  The Somatostatin Receptor-4 Agonist J-2156 Alleviates Mechanical Hypersensitivity in a Rat Model of Breast Cancer Induced Bone Pain.

Authors:  Priyank A Shenoy; Andy Kuo; Nemat Khan; Louise Gorham; Janet R Nicholson; Laura Corradini; Irina Vetter; Maree T Smith
Journal:  Front Pharmacol       Date:  2018-05-15       Impact factor: 5.810

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.